These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 22818080)
21. A series of structurally simple chloroquine chemosensitizing dibemethin derivatives that inhibit chloroquine transport by PfCRT. Zishiri VK; Hunter R; Smith PJ; Taylor D; Summers R; Kirk K; Martin RE; Egan TJ Eur J Med Chem; 2011 May; 46(5):1729-42. PubMed ID: 21396749 [TBL] [Abstract][Full Text] [Related]
22. Malagashanine potentiates chloroquine antimalarial activity in drug resistant Plasmodium malaria by modifying both its efflux and influx. Ramanitrahasimbola D; Rasoanaivo P; Ratsimamanga S; Vial H Mol Biochem Parasitol; 2006 Mar; 146(1):58-67. PubMed ID: 16313982 [TBL] [Abstract][Full Text] [Related]
23. Ultrastructural changes associated with reversal of chloroquine resistance by verapamil in Plasmodium chabaudi. Ohsawa K; Tanabe K; Kimata I; Miki A Parasitology; 1991 Oct; 103 Pt 2():185-9. PubMed ID: 1745546 [TBL] [Abstract][Full Text] [Related]
24. Plasmodium chabaudi: association of reversal of chloroquine resistance with increased accumulation of chloroquine in resistant parasites. Miki A; Tanabe K; Nakayama T; Kiryon C; Ohsawa K Exp Parasitol; 1992 Mar; 74(2):134-42. PubMed ID: 1740175 [TBL] [Abstract][Full Text] [Related]
25. Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains. Gemma S; Kukreja G; Fattorusso C; Persico M; Romano MP; Altarelli M; Savini L; Campiani G; Fattorusso E; Basilico N; Taramelli D; Yardley V; Butini S Bioorg Med Chem Lett; 2006 Oct; 16(20):5384-8. PubMed ID: 16890433 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds. Rojas Ruiz FA; García-Sánchez RN; Estupiñan SV; Gómez-Barrio A; Torres Amado DF; Pérez-Solórzano BM; Nogal-Ruiz JJ; Martínez-Fernández AR; Kouznetsov VV Bioorg Med Chem; 2011 Aug; 19(15):4562-73. PubMed ID: 21723734 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and in vitro and in vivo antimalarial activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives. Ryckebusch A; Deprez-Poulain R; Maes L; Debreu-Fontaine MA; Mouray E; Grellier P; Sergheraert C J Med Chem; 2003 Feb; 46(4):542-57. PubMed ID: 12570376 [TBL] [Abstract][Full Text] [Related]
28. Modifications in the rhythm of schizogony in Plasmodium chabaudi chabaudi associated with the selection of chloroquine resistance. Coquelin F; Biarnais T; Deharo E; Peters W; Chabaud A; Landau I Parasitol Res; 1997; 83(5):504-9. PubMed ID: 9197401 [TBL] [Abstract][Full Text] [Related]
29. Chloroquine transport via the malaria parasite's chloroquine resistance transporter. Martin RE; Marchetti RV; Cowan AI; Howitt SM; Bröer S; Kirk K Science; 2009 Sep; 325(5948):1680-2. PubMed ID: 19779197 [TBL] [Abstract][Full Text] [Related]
30. Chloroquine-induced nitric oxide increase and cell death is dependent on cellular GSH depletion in A172 human glioblastoma cells. Park BC; Park SH; Paek SH; Park SY; Kwak MK; Choi HG; Yong CS; Yoo BK; Kim JA Toxicol Lett; 2008 Apr; 178(1):52-60. PubMed ID: 18359172 [TBL] [Abstract][Full Text] [Related]
31. Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya. Mang'era CM; Mbai FN; Omedo IA; Mireji PO; Omar SA Acta Trop; 2012 Sep; 123(3):202-7. PubMed ID: 22641431 [TBL] [Abstract][Full Text] [Related]
32. Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure. Daher W; Biot C; Fandeur T; Jouin H; Pelinski L; Viscogliosi E; Fraisse L; Pradines B; Brocard J; Khalife J; Dive D Malar J; 2006 Feb; 5():11. PubMed ID: 16464254 [TBL] [Abstract][Full Text] [Related]
34. A new class of phenazines with activity against a chloroquine resistant Plasmodium falciparum strain and antimicrobial activity. Hussain H; Specht S; Sarite SR; Saeftel M; Hoerauf A; Schulz B; Krohn K J Med Chem; 2011 Jul; 54(13):4913-7. PubMed ID: 21591758 [TBL] [Abstract][Full Text] [Related]
35. Current understanding of the molecular basis of chloroquine-resistance in Plasmodium falciparum. Jiang H; Joy DA; Furuya T; Su XZ J Postgrad Med; 2006; 52(4):271-6. PubMed ID: 17102545 [TBL] [Abstract][Full Text] [Related]
36. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum. van Schalkwyk DA; Egan TJ Drug Resist Updat; 2006; 9(4-5):211-26. PubMed ID: 17064951 [TBL] [Abstract][Full Text] [Related]
37. Dual-acting diamine antiplasmodial and chloroquine resistance modulating agents. Yeh S; Smith PJ; Chibale K Biochem Pharmacol; 2006 Jul; 72(2):156-65. PubMed ID: 16730664 [TBL] [Abstract][Full Text] [Related]
38. Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice. Siddiqi NJ; Alhomida AS In Vivo; 1999; 13(6):547-50. PubMed ID: 10757052 [TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo chloroquine-potentiating action of Strychnos myrtoides alkaloids against chloroquine-resistant strains of Plasmodium malaria. Rasoanaivo P; Ratsimamanga-Urverg S; Milijaona R; Rafatro H; Rakoto-Ratsimamanga A; Galeffi C; Nicoletti M Planta Med; 1994 Feb; 60(1):13-6. PubMed ID: 8134408 [TBL] [Abstract][Full Text] [Related]
40. Fluoxetine potentiates chloroquine and mefloquine effect on multidrug-resistant Plasmodium falciparum in vitro. Khairul MF; Min TH; Low JH; Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS Jpn J Infect Dis; 2006 Oct; 59(5):329-31. PubMed ID: 17060702 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]